COMP <GO>
ZYBT vs MNOV // RSI-14 & 200D SMA MOMENTUM
Zhengye Biotechnology Holding Limited (Class A) (NASDAQ) VS. Medicinova Inc (NASDAQ) • 15-METRIC TALLY: ZYBT 5
— MNOV 2
▲ RSI-14 & 200D SMA MOMENTUM LEADER: ZYBT
LAST: $1.30 (-9.09%) • MKT CAP: $67.8M
rsi-technicals
43.1
LAST: $1.40 (0.00%) • MKT CAP: $68.9M
rsi-technicals
38.4
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZYBT VS. MNOV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZYBT | MNOV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -22.30% | -35.00% | +12.70 | ZYBT | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.61% | -14.24% | +16.85 | ZYBT | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 68.00% | -128.00 | MNOV | /net-margins <GO> |
| Revenue Growth (YoY) | -34.80% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.90 | 0.20 | +1.70 | ZYBT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | ZYBT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 43.1 | 38.4 | +4.67 | ZYBT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 5.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $67.8M | $68.9M | -$1.1M | MNOV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZYBT REV | MNOV REV | ZYBT GROSS % | MNOV GROSS % | ZYBT FCF | MNOV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.6M | $409.7K | 20.5% | — | $1.8M | -$9.8M |
| FY 2024 | $25.5M | $0 | 49.0% | — | $3.8M | -$10.6M |
| FY 2023 | — | $1.0M | — | — | — | -$7.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZYBT // BETA —
MNOV // BETA —